The ongoing Daro-PET study set out to evaluate the ability of the oral androgen receptor inhibitor darolutamide (Nubeqa) to ...

The Foresight CLARITY test offers greater prognostic accuracy than PET/CT scans in large B-cell lymphoma by detecting ctDNA-MRD negativity, indicating better patient outcomes. ctDNA-MRD testing showed ...

A newer type of prostate cancer scan called 64 Cu-SAR-bisPSMA found more than twice as many cancer spots as a commonly used PSMA PET scan in men whose prostate-specific antigen (PSA) was rising after ...

Impact of BRCA alterations on androgen receptor pathway inhibition treatment outcome in advanced prostate cancer. Predictive associations between serum dehydroepiandrosterone sulfate (DHEAS) and race ...

Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major ...